Order Article Reprints

Lugtenberg RT, de Groot S, Houtsma D, Dezentjé VO, Vulink AJE, Fischer MJ, Portielje JEA, van der Hoeven JJM, Gelderblom H, Pijl H, et al. Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer. Cancers. 2023; 15(6):1691. https://doi.org/10.3390/cancers15061691

Lugtenberg, Rieneke T., Stefanie de Groot, Danny Houtsma, Vincent O. Dezentjé, Annelie J. E. Vulink, Maarten J. Fischer, Johanneke E. A. Portielje, Jacobus J. M. van der Hoeven, Hans Gelderblom, Hanno Pijl, and et al. 2023. "Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer" Cancers 15, no. 6: 1691. https://doi.org/10.3390/cancers15061691

Lugtenberg, R. T., de Groot, S., Houtsma, D., Dezentjé, V. O., Vulink, A. J. E., Fischer, M. J., Portielje, J. E. A., van der Hoeven, J. J. M., Gelderblom, H., Pijl, H., & Kroep, J. R. (2023). Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer. Cancers, 15(6), 1691. https://doi.org/10.3390/cancers15061691